Inovio Pharmaceuticals (INO)
(Delayed Data from NSDQ)
$11.13 USD
+0.07 (0.63%)
Updated Jul 16, 2024 04:00 PM ET
After-Market: $11.14 +0.01 (0.09%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Brokerage Reports
Inovio Pharmaceuticals, Inc. [INO]
Reports for Purchase
Showing records 341 - 360 ( 364 total )
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Products
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Products
A FOUR STAR PATENTVEST IP VALUE COMPANY - 2011 "BEST AND BRIGHTEST" PATENTVEST REPORTS
Provider: MDB CAPITAL GROUP LLC
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Products
Commences Randomized Phase 2 Trial for the Treatment of Cervical Dysplasia
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Products
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Products
Commences Randomized Phase 2 Trial for the Treatment of Cervical Dysplasia
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Products
Life Sciences: Highlights from JP Morgan - Key 2011 Drivers for Several Companies Under Coverage.
Provider: RODMAN & RENSHAW, CO.
Analyst: NOCHOMOVITZ Y
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Products
2010 RECAP & 2011 PREVIEW
Provider: RODMAN & RENSHAW, CO.
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Products
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Products
3Q10 - POWER OF DNA VACCINE TECHNOLOGY PLATFORM SEEN
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Products
HIV Prevention Trial of PENNVAX-B Fully Enrolled -Interim Data YE10, Final Data 2Q11
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Products
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Products
IMPRESSIVE RESULTS OF VGX-3100 PHASE 1 TRIAL UNVEIL POWER OF DNA VACCINES
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Products
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Products
2Q10 UPDATE - CERVICAL CANCER VACCINE DATA IN SEPTEMBER TO DRIVE VALUE
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Products
Initiates Phase 1 Study of Avian Influenza Vaccine in Health Volunteers
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Products
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Products
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Products
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Products
1Q10 UPDATE - CERVICAL CANCER VACCINE TRIAL FULLY ENROLLED -DATA 2H10
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Products
1Q10 UPDATE - CERVICAL CANCER VACCINE TRIAL FULLY ENROLLED - DATA 2H10
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R